Search

Your search keyword '"Cloutier, Stéphanie"' showing total 7 results
Start Over Author "Cloutier, Stéphanie" Journal haemophilia
7 results on '"Cloutier, Stéphanie"'

1. Post‐procedural bleeding rate and haemostatic treatment use for dental procedures before and after the implementation of a standardized protocol for people with inherited bleeding disorders

Author

Champagne, Pier‐Ann, primary, Bourassa, Michelle, additional, Desjardins, Marie‐Pier, additional, Cloutier, Stéphanie, additional, Demers, Christine, additional, Singbo, Narcisse Ulrich, additional, Néron, Hélène, additional, and Pelland‐Marcotte, Marie‐Claude, additional

Published
2022
Full Text
View/download PDF

2. Evaluation of anti‐factor VIII antibodies in haemophilia A subjects switching products following a provincial tender

Author

Dubé, Evemie, primary, Merlen, Clémence, additional, Bonnefoy, Arnaud, additional, Gauthier, Julie, additional, Castilloux, Jean‐François, additional, Charlebois, Janie, additional, Cloutier, Stéphanie, additional, Demers, Christine, additional, Sabapathy, Christine A., additional, St‐Louis, Jean, additional, Vézina, Catherine, additional, Warner, Margaret, additional, and Rivard, Georges‐Étienne, additional

Published
2021
Full Text
View/download PDF

3. Patterns of joint damage in severe haemophilia A treated with prophylaxis

Author

Goren, Rachel, primary, Pullenayegum, Eleanor, additional, Blanchette, Victor S., additional, Dover, Saunya, additional, Carcao, Manuel, additional, Israels, Sara J., additional, Chan, Anthony, additional, Rivard, Georges E., additional, Steele, MacGregor, additional, Cloutier, Stéphanie, additional, Klaassen, Robert J., additional, Sinha, Roona, additional, Price, Victoria E., additional, Laferriere, Nicole, additional, Paradis, Elizabeth, additional, Wu, John K., additional, and Feldman, Brian M., additional

Published
2021
Full Text
View/download PDF

4. A prospective surveillance study in haemophilia B patients following a population switch to recombinant factor IX (nonacog gamma)

Author

Dubé, Evemie, primary, Merlen, Clémence, additional, Bonnefoy, Arnaud, additional, Gauthier, Julie, additional, Castilloux, Jean‐François, additional, Cloutier, Stéphanie, additional, Demers, Christine, additional, Sabapathy, Christine A., additional, St‐Louis, Jean, additional, Vézina, Catherine, additional, Warner, Margaret, additional, and Rivard, Georges‐Étienne, additional

Published
2021
Full Text
View/download PDF

6. Evaluation of anti‐factor VIII antibodies in haemophilia A subjects switching products following a provincial tender.

Author

Dubé, Evemie, Merlen, Clémence, Bonnefoy, Arnaud, Gauthier, Julie, Castilloux, Jean‐François, Charlebois, Janie, Cloutier, Stéphanie, Demers, Christine, Sabapathy, Christine A., St‐Louis, Jean, Vézina, Catherine, Warner, Margaret, and Rivard, Georges‐Étienne

Subjects
BLOOD coagulation factor VIII antibodies, HEMOPHILIA, VON Willebrand disease, BLOOD coagulation factor VIII, CHILD patients, HEMOPHILIACS, NEUTRALIZATION tests
Abstract

Evaluation of anti-factor VIII antibodies in haemophilia A subjects switching products following a provincial tender Haemophilia A, inhibitor, recombinant factor VIII, bleeds, factor VIII usage, switching products Keywords: bleeds; factor VIII usage; haemophilia A; inhibitor; recombinant factor VIII; switching products EN bleeds factor VIII usage haemophilia A inhibitor recombinant factor VIII switching products e1 e4 4 01/13/22 20220101 NES 220101 In 2018, following a provincial tender process, most persons with haemophilia A (PWHA) in the province of Quebec (Canada) were switched to the two recombinant B-domain-truncated factor VIII (FVIII) known as Zonovate® (NovoNordisk, Mississauga, Canada) and Nuwiq® (Octapharma AG, Lachen, Switzerland) with an estimated market distribution of respectively 53% and 47%. [Extracted from the article]

Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results